United States Acoustic Neuroma Market Insight
Published: 23 May 2026 | Report Format: Electronic (PDF)
The US acoustic neuroma market is expanding with a CAGR of 7.6%, and it's being linked to a bunch of things, like more people being diagnosed with vestibular schwannoma, greater awareness of early neurological diagnosis, and the growing use of advanced imaging, plus radiation therapy and also less invasive surgical treatment options moving across hospitals and specialty neurology centers.
U.S. Acoustic Neuroma Market Insights Forecasts to 2035
- The US Acoustic Neuroma Market Size Was Estimated at USD 1.42 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.6% from 2025 to 2035
- The US Acoustic Neuroma Market Size is Expected to Reach USD 2.96 Billion by 2035
Notable Insights for U.S. Acoustic Neuroma Market
- By treatment type, the radiation therapy segment dominated the market, generating approximately USD 0.64 Billion in revenue in 2024.
- According to the application, the hospital and specialty neurology clinic segment will register the fastest growth, backed by increasing patient diagnosis rates and rising adoption of advanced stereotactic radiosurgery technologies.
- Around 63% of the neuro-oncology and ENT treatment centers in the United States use advanced MRI imaging plus radiation therapy setups for acoustic neuroma diagnosis, and the whole planning bit. Meanwhile, about 58% of neurosurgeons lean on minimally invasive surgery tactics, along with precision monitoring systems, to help patients bounce back faster and to keep treatment complications lower.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Advanced Healthcare Intelligence and Disease Trend Analysis
Decisions Advisors delivers specialized healthcare market intelligence, disease prevalence tracking, treatment adoption analysis, and strategic forecasting solutions to support informed business and clinical decision-making.
- Data-Backed Clinical Research and Predictive Industry Assessment
Our research methodology combines physician interviews, healthcare database validation, scientific literature analysis, and predictive analytical modelling to provide accurate market estimations and future treatment trend evaluations.
- Comprehensive Therapeutic Landscape and Innovation Monitoring
We provide detailed insights into competitive treatment developments, emerging medical technologies, regulatory frameworks, patient care trends, and investment opportunities shaping the healthcare and life sciences industries.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Acoustic Neuroma market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Acoustic Neuroma Market
- Elekta AB
- Varian Medical Systems, Inc.
- Medtronic plc
- Siemens Healthineers AG
- GE HealthCare Technologies Inc.
- Stryker Corporation
- Accuray Incorporated
- Canon Medical Systems Corporation
- Others
Recent Developments:
- In April 2026, Elekta AB introduced advanced stereotactic radiosurgery systems with AI-assisted treatment planning capabilities for acoustic neuroma therapy applications across the US.
- In October 2025, Varian Medical Systems, Inc. expanded its precision radiation oncology portfolio by launching enhanced image-guided therapy solutions designed for complex neurological tumor treatments and minimally invasive care procedures.
Market Segmentation:
United States Acoustic Neuroma Market, By Treatment Type
- Radiation Therapy
- Surgery
- Observation & Monitoring
- Others
United States Acoustic Neuroma Market, By Diagnosis Type
- MRI Imaging
- CT Scanning
- Hearing Tests
- Neurological Examinations
- Others
United States Acoustic Neuroma Market, By End User
- Hospitals
- Specialty Neurology Clinics
- Cancer Treatment Centers
- Ambulatory Surgical Centers
- Others
Expert Views:
The US acoustic neuroma market is likely to see stable growth, mostly because healthcare providers are putting more effort into improved neurological diagnosis, less invasive treatments, and more precise treatment strategies for vestibular schwannoma care. A lot of analysts suggest that radiation therapy plus hospital-based treatment use cases will still be the main driver, and that’s not surprising. At the same time, constant progress in AI-assisted imaging, robotic neurosurgery, and aimed radiosurgery technologies should help elevate patient outcomes, which may in turn speed up market expansion in the years ahead.
Author: Komal and Radhika By Spherical Insights and Consulting